TQC3927

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQC3927, covering 2024-10-29 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease [Phase 1]